The significant increases in the percentage of CD4+ and CD8+ T cells in spleens of 4T1 tumor–bearing mice were observed following pharmacogenetic inhibition of CeMCRH neurons (Supplemental Figure 14, J and K). The gene discussed is CD4; the disease is neoplasm.